Susquehanna Maintains Positive on NOV, Lowers Price Target to $22

Benzinga Newsdesk www.benzinga.com Negative 85.3%

Neg 85.3% Neu 0% Pos 0%

Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and lowers the price target from $24 to $22.